Advertisement

Topics

Antares Pharma, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

21:41 EDT 6 Aug 2018 | BioPortfolio Reports

Antares Pharma, Inc. Strategy, SWOT and Corporate Finance Report


Summary


Antares Pharma, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Antares Pharma Antares or 'the company' is a specialty pharmaceutical company focusing on selfinjection pharmaceutical products and technologies, and topical gelbased products. The company operates in the US, Europe and other regions of the world. It is headquartered in Ewing, New Jersey.


Scope


Detailed information on Antares Pharma, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Antares Pharma, Inc. in the form of a SWOT analysis

An indepth view of the business model of Antares Pharma, Inc. including a breakdown and examination of key business segments

Intelligence on Antares Pharma, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Antares Pharma, Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Antares Pharma, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Antares Pharma, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Antares Pharma, Inc.'s business structure, strategy and prospects.

Original Article: Antares Pharma, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Antares Pharma, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...